Jasper Therapeutics, Inc. announced presentations of data from its preclinical and healthy volunteers studies of briquilimab, as well as trial-in-progress presentations from its BEACON and SPOTLIGHT.
Jasper Therapeutics, Inc. (NASDAQ:JSPRW – Get Free Report) was the target of a large drop in short interest in the month of May. As of May 15th, there was short interest totalling 3,800 shares, a drop of 19.1% from the April 30th total of 4,700 shares. Based on an average daily trading volume, of 21,900 […]
Jasper Therapeutics, Inc. (NASDAQ:JSPRW – Get Free Report) was the target of a large drop in short interest during the month of May. As of May 15th, there was short interest totalling 3,800 shares, a drop of 19.1% from the April 30th total of 4,700 shares. Based on an average daily trading volume, of 21,900 […]
REDWOOD CITY, Calif., May 30, 2024 (GLOBE NEWSWIRE) Jasper Therapeutics, Inc. (NASDAQ:JSPR) (Jasper), a clinical stage biotechnology company focused on development of briquilimab, a novel antibody therapy targeting
Jasper Therapeutics to Present Data on Briquilimab in Mast globenewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from globenewswire.com Daily Mail and Mail on Sunday newspapers.